Use of lung transplantation survival models to refine patient selection in cystic fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 171, Issue 9, 2005, Pages 1053-1059

  Liou, Theodore G ^a   Adler, Frederick R ^a   Huang, David ^a  

^a NONE

Author keywords

Age; Arthropathy; Burkholderia cepacia; Cox proportional hazards model; Organ allocation

Indexed keywords

ADULT; ARTHROPATHY; ARTICLE; BURKHOLDERIA CEPACIA; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; HUMAN; KAPLAN MEIER METHOD; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; AGE FACTORS; BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; COMORBIDITY; CYSTIC FIBROSIS; FEMALE; HUMANS; LUNG TRANSPLANTATION; MALE; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TISSUE AND ORGAN PROCUREMENT;

EID: 18144404644     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200407-900OC     Document Type: Article

References (29)

1. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry 2002 annual data report to the center directors. Bethesda, Md: Cystic Fibrosis Foundation; 2002.
2. Scott J, Higenbottam T, Hutter J, Hodson M, Stewart S, Penketh A, Wallwork J. Heart-lung transplantation for cystic fibrosis. Lancet 1988;2:192-196.
3. Ramirez JC, Patterson GA, Winton TL, de Hoyos AL, Miller JD, Maurer JR. Toronto Lung Transplant Group. Bilateral lung transplantation for cystic fibrosis. J Thorac Cardiovasc Surg 1992;103:287-294.
4. Starnes VA, Barr ML, Cohen RG, Hagen JA, Wells WJ, Horn MV, Schenkel FA. Living-donor lobar lung transplantation experience: intermediate results. J Thorac Cardiovasc Surg 1996;112:1284-1291.
5. Liou TG, Adler FR, Fitzsimmons SC, Cahill BC, Hibbs JR, Marshall BC. Predictive five year survivorship model of cystic fibrosis. Am J Epidemiol 2001;153:345-352.
6. Liou TG, Adler FR, Cahill BC, Fitzsimmons SC, Huang D, Hibbs JR, Marshall BC. Survival effect of lung transplantation for patients with cystic fibrosis. JAMA 2001;286:2686-2689.
7. Liou TG, Adler FR, Cahill BC, Marshall BC. Priorities for lung transplantation among patients with cystic fibrosis. JAMA 2002;287:1525.
8. Chaparro C, Maurer J, Gutierrez C, Krajden M, Chan C, Winton T, Keshavjee S, Scavuzzo M, Tullis E, Hutcheon M, et al. Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am J Respir Crit Care Med 2001;163:43-48.
9. Egan TM, Detterbeck FC, Mill MR, Bleiweis MS, Aris R, Paradowski L, Retsch-Bogart G, Mueller BS. Long term results of lung transplantation for cystic fibrosis. Eur J Cardiothorac Surg 2002;22:602-609.
10. Aris RM, Routh JC. LiPuma JJ, Heath DG, Gilligan PH. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex: survival linked to genomovar type. Am J Respir Crit Care Med 2001;164:2102-2106.
11. De Soyza A, McDowell A, Archer L, Dark JH, Elborn SJ, Mahenthiralingam E, Gould K, Corns PA. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 2001;358:1780-1781.
12. Aurora P, Gassas A, Ehtisham S, Whitehead B, Whitmore P, Rees PG, Tsang VT, Elliott MJ, De Leval M. The effect of pre-lung transplant clinical status on post-transplant survival of children with cystic fibrosis. Eur Respir J 2000;16:1061-1064.
13. Trulock EP, Ardehali A, Garrity ER Jr, Grover FL, Robbins MK. OPTN/UNOS Conference on Lung Allocation Policy; March 13, 2003; Chicago, IL.
14. Liou TG, Adler FR, Huang D. Survival after lung transplantation for cystic fibrosis: implications for patient selection. Pediatr Pulmonol 2004;38:319.
15. Chambers JM, editor. Programming with data: a guide to the S language. New York: Springer; 1998.
16. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999;159:179-187.
17. Klein JP, Moeschberger ML. Semiparametric proportional hazards regression with fixed covariates. In: Klein JP, Moeschberger ML, editors. Survival analysis: techniques for censored and truncated data, 1st ed. New York: Springer; 1997. p. 229.
18. Zar JH. Biostatistical analysis, 4th ed. Upper Saddle River, NJ: Prentice Hall; 1998.
19. Yankaskas JR, Mallory GB Jr. The Consensus Committee. Lung transplantation in cystic fibrosis. Chest 1998;113:217-226.
20. Maurer JR, Frost AE, Glanville AR, Estenne M, Higenbottam T, Aris R, Barbers RG, Barst R, Baz MA, de Boer W, et al. International guidelines for the selection of lung transplant candidates. Am J Respir Crit Care Med 1998;158:335-339.
21. Levine SM. The Transplant/Immunology Network of the American College of Chest Physicians: a survey of clinical practice of lung transplantation in North America. Chest 2004;125:1224-1238.
22. Rosenfeld M, Davis R, FitzSimmons S, Pepe M, Ramsey B. Gender gap in cystic fibrosis mortality. Am J Epidemiol 1997;145:794-803.
23. Johnson S, Knox AJ. Arthropathy in cystic fibrosis. Respir Med 1994;88:567-570.
24. Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992;326:1187-1191.
25. Massard G, Shennib H, Metras D, Camboulives J, Viard L, Mulder DS, Tchervenkov CI, Morin J-F, Giudicelli R, Noirclerc M. Double-lung transplantation in mechanically ventilated patients with cystic fibrosis. Ann Thorac Surg 1993;55:1087-1092.
26. Sood N, Paradowski LJ, Yankaskas JR. Outcomes of intensive care unit care in adults with cystic fibrosis. Am 1 Respir Crit Care Med 2001;163:335-338.
27. Manno G, Dalmastri C, Tabacchioni S, Vandamme P, Lorini R, Minicucci L, Romano L, Giannattasio A, Chiarini L, Bevivino A. Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an Italian cystic fibrosis center. J Clin Microbiol 2004;42:1491-1497.
28. Liou TG, Cahill BC, Adler FR, Marshall BC. Selection of patients with cystic fibrosis for lung transplantation. Curr Opin Pulm Med 2002;8;535-541.
29. Quittner AL, Sweeny S, Watrous M, Munzenberger P, Bearss K, Nitza AG, Fisher LA, Henry B. Translation and linguistic validation of a disease-specific quality of life measure for cystic fibrosis. J Pediatr Psychol 2000;25:403-414.